SCHEMBL16222

SCHEMBL16222

C[C@@H]1CN(C[C@H]2CN(S(=O)(=O)c3cccs3)CCN2c2ccc(C(C)(O)C(F)(F)F)cc2)CCO1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 12/20 0.74
GCKR Q14397 8/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16328 1.00 GCK (0.74) GCKGCKR
SCHEMBL12078625 1.00 GCK (0.74) GCKGCKR
SCHEMBL18106 1.00 GCK (0.74) GCKGCKR
SCHEMBL12078949 1.00 GCK (0.74) GCKGCKR
SCHEMBL12078466 1.00 GCK (0.74) GCKGCKR
SCHEMBL18102 1.00 GCK (0.74) GCKGCKR
SCHEMBL18104 1.00 GCK (0.74) GCKGCKR
SCHEMBL17767 1.00 GCK (0.74) GCKGCKR
SCHEMBL12078728 1.00 GCK (0.74) GCKGCKR
SCHEMBL12093454 1.00 GCK (0.74) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed